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Abstract
Background: Physical activity (PA)/exercise have become an integral part of the management of type 2 diabetes
mellitus (T2DM). However, current guidelines are difficult to put into action in this population due to a number of
barriers, especially the lack of acceptable, feasible, and validated behavioral intervention strategies. The present
manuscript reports the rationale, study design and methods, and design considerations of the Italian Diabetes and
Exercise Study (IDES)-2, a randomized controlled trial testing the efficacy of a behavior change strategy in increasing
total daily PA and reducing sedentary time (SED-time) in patients with T2DM.
Methods/Design: Starting 7 January 2014, the IDES_2 began enrolling 300 patients with known T2DM of at least
1-year duration in three tertiary referral outpatient Diabetes Clinics in Rome. Additional requirements are age 40 to
80 years, body mass index 27 to 40 kg/m2, sedentary lifestyle, and physically inactive for at least 6 months, ability to
walk 1.6 km without assistance, and eligibility after cardiovascular evaluation. Patients are randomized by center and
within each center, by age and type of diabetes treatment to either the intervention or the control group. Patients
in the intervention (INT) group (n = 150) receive theoretical and practical exercise counseling consisting of
aggregated behavior change techniques (one individual theoretical counseling session plus eight twice-a-week
individual theoretical and practical exercise counseling sessions) once a year for 3 years. Patients in the control
(CON) group (n = 150), receive standard care, including general physician recommendations for daily PA. The
primary outcomes are total daily PA and SED-time, as measured objectively by the use of an accelerometer.
Secondary outcomes include physical fitness, modifiable cardiovascular risk factors, musculoskeletal disturbances,
well-being/depression, and health-related quality of life.
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Discussion: The behavioral intervention strategy tested in the IDES_2 is based on solid theoretical grounds and
uses several behavioral change techniques, two factors which were found to improve effectiveness of behavioral
intervention. In addition, physicians and exercise specialists have been specifically trained for counselling/
prescribing and supervising PA/exercise, respectively, in subjects suffering from metabolic disorders. Finally, the
large sample size, the long study duration, and the objective measurement of PA allow statistically significant and
scientifically robust conclusions to be drawn on the feasibility and efficacy of this intervention in T2DM patients.
Trial registration: ClinicalTrials.gov; NCT01600937; 10 October 2012.
Keywords: Type 2 diabetes, Physical activity, Randomized controlled trial, Behavior change, Accelerometer
Background
Approximately 592 million people worldwide are pre-
dicted to be diagnosed with type 2 diabetes mellitus
(T2DM) by the year 2035 [1]. This epidemic of T2DM is
causally related to the rising incidence of obesity [2],
with the increased calorie consumption combined with
reduced energy expenditure contributing to the devel-
opment of both conditions [3]. Recent data from the
National Health and Nutrition Examination Survey
(NHANES) highlight that the dramatic increase of
obesity levels among US adults in the general popula-
tion is mainly due to physical inactivity rather than to
caloric intake [4]. In fact, another report from the
NHANES indicates that less than 50 % of US adults
achieve the recommended level of physical activity
(PA) and ~30 % of them engage in no PA at all, though
projections suggest an improvement [5]. The problem
of sedentary behavior as well as of physical inactivity is
even greater among people with T2DM or those at
highest risk for developing this condition, who are well
below national norms for PA [6]. Therefore, PA is now
considered, together with diet and medication, as a
cornerstone of T2DM management [7–9].
The joint position statement of the American College
of Sports Medicine (ACSM) and the American Diabetes
Association (ADA) [10] recommends that individuals
with T2DM perform at least 150 minutes/week of
moderate-to-vigorous aerobic exercise, plus moderate-
to-vigorous resistance training at least 2–3 days/week. In
addition, the ACSM/ADA guidelines recommend that
individuals train under the supervision of qualified exer-
cise trainers, particularly when undertaking resistance
exercise, to ensure optimal health benefits and to
minimize injuries; individuals are also encouraged to
increase total daily unstructured (commuting, occupa-
tional, home, and leisure time [LT]) PA. These recom-
mendations are based on a large body of experimental
evidence which has been accumulating during the last
decade. Two randomized controlled trials (RCTs), the
Diabetes Aerobic and Resistance Exercise (DARE) study
[11] and the Health benefits of Aerobic and Resistance
Training in individuals with type 2 Diabetes (HART-D)
study [12], have demonstrated that combined aerobic
and resistance training is more effective than either
one alone in reducing hemoglobin (Hb) A1c in patients
with type 2 diabetes. A systematic review and meta-
analysis including the DARE and HART-D studies showed
that structured exercise training, either aerobic, resistance,
or both, is associated with HbA1c reduction in patients
with type 2 diabetes, especially if more than 150 minutes/
week is undertaken and when combined with dietary ad-
vice [13]. Furthermore, another RCT, the Italian Diabetes
and Exercise Study (IDES), showed that a strategy com-
bining a supervised mixed (aerobic and resistance)
exercise training program with structured exercise coun-
seling was more effective than counseling alone in im-
proving physical fitness and quality of life (QoL),
ameliorating HbA1c and other modifiable cardiovascular
risk factors, reducing coronary heart disease (CHD) 10-
year risk scores, and decreasing the number and/or dosage
of medications, in a large cohort of sedentary subjects
with T2DM [14–16]. Finally, recent findings suggest that
higher sedentary time (SED-time) in T2DM individuals is
associated with higher metabolic risk, independently of
measured confounders and time spent in moderate-to-
vigorous PA (MVPA) [17, 18], thus supporting the
hypothesis that the biological responses to SED-time likely
influence metabolic risk through pathways distinct from
those of MVPA [19, 20].
However, it is difficult for people with T2DM to put into
action these exercise recommendations for a number of
external and internal barriers [21]. Data from trials for
T2DM prevention [22, 23] and treatment [24] suggest the
need to identify effective strategies to promote an ad-
equate amount of PA in sedentary subjects such as those
suffering from metabolic disorders. Unfortunately, avail-
able studies have applied PA-targeted behavioral interven-
tions that are either heterogeneous or insufficiently
detailed [25]. Moreover, these studies generally involved
small samples, and changes in PA were not objectively
measured. In the IDES, supervised training, in addition to
providing significant health benefits, was successful also in
promoting PA outside the supervised sessions, likely by
improving patient’s knowledge, confidence, and sureness
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in his/her ability to perform PA effectively and safely on
his/her own.
The IDES_2 is an open-label, parallel RCT aimed at
assessing the efficacy of a behavioral intervention strat-
egy derived from the IDES protocol in increasing total
daily PA and reducing SED-time in patients with T2DM.
This strategy combines the seven-step theoretical exer-
cise counseling [26] provided to all IDES participants
[27] with eight bi-weekly sessions, supervised by an exer-
cise specialist in a dedicated gym facility. These sessions,
which in the IDES were administered to the intervention
group for the entire 12-month study duration [27], serve
as a theoretical and practical counseling to promote and
maintain a physically active behavior. Intervention is re-
peated every 12 months for 3 years, and PA is objectively
monitored throughout the study by the use of an accel-
erometer. This intervention strategy is compared with
current approach, that is, standard medical care includ-
ing general physician recommendations on PA.
Methods/Design
Ethics
The study complies with the Declaration of Helsinki.
The research protocol (version #3, 15 February 2012),
which follows the SPIRIT guideline (see Additional file
1: Appendix B), has been approved by the Comitato
Etico dell’Azienda Ospedaliera Sant’Andrea Prot. n. 212/
2012 and written informed consent (see Additional file
1: Appendix C1) is provided by each participant. Partici-
pants are not provided with an honorarium. The flow
chart of the study is presented in Fig. 1.
Participants
The main entry criterion is known T2DM (defined by the
ADA criteria) [28] of at least 1-year duration. Additional
requirements are age 40 to 80 years, body mass index
(BMI) 27 to 40 kg/m2, sedentary lifestyle (that is, more
than 8 hours/day spent in any waking behavior character-
ized by an energy expenditure ≤1.5 metabolic equivalents
(METs) while in a sitting or reclining posture) [29] and
physically inactive (that is, insufficient amounts of PA ac-
cording to current guidelines) [30] for at least 6 months,
ability to walk 1.6 km without assistance, and eligibility
after cardiologic evaluation.
In order to preserve high internal validity and reduce
the risk of adverse events, the criteria presented in
Table 1 are used to exclude individuals with conditions
that limit or contraindicate PA, affect conduct of the
trial, reduce lifespan, and/or affect the safety of
intervention.
Investigators
A specific strategy was implemented to train physicians
and exercise specialists involved in the IDES and IDES_2
in order to improve efficacy and safety of intervention
and patient adherence and to minimize drop-out. The
training path dedicated to physicians (diabetologists)
was aimed at increasing their awareness of the import-
ance of PA/exercise as a preventive and therapeutic
measure in T2DM and other metabolic disorders as well
as at instructing them on how to administer a structured
exercise counselling and prescribe PA/exercise to sub-
jects suffering from these disease conditions. The train-
ing path dedicated to exercise specialists was aimed at
instructing professionals with a Bachelor’s degree in ex-
ercise science on how to assess physical fitness and PA
volume and to supervise exercise sessions, including
monitoring of clinical parameters, in individuals with
metabolic disorders. At the end of the training program,
exercise specialists were certified for assisting these
patients in their participation to exercise training pro-
grams. All these activities were proposed and managed
by the Metabolic Fitness Association and were detailed
in the online supplemental material of a previous IDES
publication [14]. To minimize drop-out and reduce the
attrition bias due to missing data, both physicians and
exercise specialists have been specifically instructed on
how to promote participant retention in the trial. In par-
ticular, investigators have been asked to contact partici-
pants at regular intervals, and subjects from both groups
are offered access to intervention after the trial. More-
over, investigators have been instructed to keep up-to-
date contact information for participants and to collect
complete data for both the primary and secondary
outcomes, regardless of whether subjects continue to re-
ceive the assigned treatment. This strategy was success-
fully applied to the IDES, in which adherence was high
and drop-out was low [14].
Recruitment
Three-hundred patients are being recruited in three ter-
tiary referral outpatient Diabetes Clinics in Rome begin-
ning in January 2014 (see Additional file 1: Appendix A).
All patients attending these clinics are evaluated for eli-
gibility. The recruitment process includes four visits des-
ignated as R1, R2, R3, and R4 (Table 2).
On R1, patients fulfilling the above criteria are identi-
fied based on medical history, clinical examination, and
results of the Minnesota LTPA questionnaire. Then,
patients are asked to sign a statement of informed con-
sent, are registered in the IDES_2 database available at
http://www.metabolicfitness.it/, and undergo a cardio-
logic examination for cardiovascular evaluation, includ-
ing a resting ECG and, based on clinical judgment, an
echocardiogram and/or an ECG treadmill test.
On R2, in order to objectively verify sedentary habits
and physical inactivity, eligible patients are asked to
wear an accelerometer (MyWellness Key, Technogym,
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Gambettola, IT) for 1 week [31, 32] and to report in a
daily diary the hours spent wearing the instrument and
those spent sleeping and napping. Then, patients attend a
run-in session for familiarization with testing devices and
protocols for the assessment of physical fitness.
On R3, patients are enrolled after confirming eligibil-
ity on the basis of the accelerometer readings. Then,
the baseline anthropometrical and clinical parameters
and blood and urine samples for biochemical testing
are taken, and based on these values, patients receive
a standard treatment regimen including nutritional
therapy and prescription of pharmacological agents as
needed. Subsequently, participants are asked to fill in
three questionnaires: a 50-item self-report question-
naire for musculoskeletal (MS) symptoms [33], the
World Health Organization (WHO)-5 Well-being
Index, a five-item questionnaire for screening of
depression [34]; and the Short Form (SF)-36 health
survey, with eight scales and two summary measures
evaluating physical and mental health-related QoL
[35]. Finally, participants perform another run-in
familiarization session for physical fitness assessment.
Fig. 1 Study flow chart. Sequence of recruitment and follow-up visits during year 1. Follow-up visits F1, F2, and F3 are repeated at years 2 (F4, F5, and F6)
and 3 (F7, F8, and F9), except that accelerometer is worn for 1 week at the end of the first 4-month period (F4 and F7). T2DM type 2 diabetes mellitus;
LTPA leisure-time physical activity; MS musculoskeletal; WHO World Health Organization; SF Short Form; INT intervention; CON control
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On R4, all participants undergo baseline assessment
of physical fitness, are informed about group assign-
ment, receive theoretical counseling or PA advices, ac-
cording to the study group, and are given an
accelerometer to be worn for 4 months, together with
a daily diary to report on the hours spent wearing the
instrument, sleeping and napping, and performing
non-accelerometer recordable PAs.
Randomization
Patients are randomized 1:1 to an intervention (INT)
group (n = 150), receiving a theoretical and practical ex-
ercise counseling on top of standard care, and a control
(CON) group (n = 150), receiving only standard care in-
cluding general physician recommendations for daily PA.
Randomization is stratified by center and, within each
center, by age and type of diabetes treatment (non-insu-
lin versus insulin therapy), using a permuted-block
randomization software that randomly varies the block
size. To ensure allocation concealment, randomization is
centralized at the Center for Outcomes Research and
Clinical Epidemiology (CORE). After randomization,
participants, physicians and exercise specialists are un-
blinded to group assignment, as blinding is not feasible
in exercise-intervention studies.
Follow-up
Participants from both groups will attend nine follow-up
visits, F1 to F9, at 4, 8, 12, 16, 20, 24, 30, and 36 months,
respectively (Table 2).
At F1, patients return the key and daily diaries;
anthropometrical and clinical parameters and blood
and urine samples are taken; and patients are asked
to fill in the MS, WHO-5, and SF-36 questionnaires.
Three to 5 days later, patients are seen again to discuss ac-
celerometer readings, with reinforcement of exercise
counseling (for the INT group) or PA advices (for the
CON group), as well as clinical and laboratory data, with
eventual adjustment of dietary and pharmacological
prescriptions.
At F2, F3, F4, F5, F6, F7 and F8, anthropometrical and
clinical parameters and blood and urine samples are taken,
and patients are asked to fill in the MS, WHO-5, and SF-36
questionnaires (the latter two only at F3, F4, F6 and F7),
and are given an accelerometer (to be worn for 7 days), to-
gether with the daily diary. At F4 and F7 only, participants
repeat the assessment of physical fitness. Seven to 10 days
later, patients are seen again to collect the key and daily
diaries and to discuss accelerometer readings, with
reinforcement of exercise counseling (for the INT group)
or PA advices (for the CON group). As during the F1, re-
sults of clinical and laboratory evaluation are discussed,
with eventual adjustment of dietary and pharmacological
prescriptions.
At F9, patients are given an accelerometer (to be worn
for 7 days), together with the daily diary. Seven to
10 days later, patients are seen again to collect the key
and daily diaries and to obtain anthropometrical and
clinical parameters, blood and urine samples, and meas-
urement of physical fitness at end-of-study. Patients are
also asked to fill in the MS, WHO-5, and SF-36 ques-
tionnaires for the final evaluation.
Table 1 Exclusion criteria
Unable or unwilling to give informed consent or communicate with
local study staff
Current diagnosis of psychiatric disorder or hospitalization for
depression in the past 6 months
Self-reported alcohol or substance abuse within the past 12 months
Self-reported inability to walk 2 blocks
Musculoskeletal disorders or deformities that may interfere with
participation in the intervention
History of central nervous dysfunction such as hemiparesis,
myelopathies, or cerebral ataxia
Clinical evidence of vestibular dysfunction
Postural hypotension defined as a fall in BP when changing position of
>20 mmHg (systole) or >10 mmHg (diastole)
Currently pregnant or nursing
Cancer requiring treatment in the past 5 years, except for cancers that
have clearly been cured or in the opinion of the investigator carry an
excellent prognosis (for example, stage 1 cervical cancer)
Chronic obstructive pulmonary disease
End-stage liver disease;
Chronic diabetic complications:
• recent major acute cardiovascular event, including heart attack or
stroke/transient ischemic attack(s), revascularization procedure, or
participation in a cardiac rehabilitation program within the past
3 months
• pre-proliferative and proliferative retinopathy
• macroalbuminuria and/or eGFR < 45 ml/min/1.73 m2
• severe motor and sensory neuropathy
• diabetic foot with history of ulcer
• Cardiovascular disease at cardiologic examination:
• history of cardiac arrest
• history of pulmonary embolism in the past 6 months
• unstable angina pectoris or angina pectoris at rest
• resting HR <45 beats/min or >100 beats/min
• complex ventricular arrhythmia at rest or with exercise
• uncontrolled atrial fibrillation (HR ≥100 beats/min)
• NYHA Class III or IV congestive heart failure
• acute myocarditis, pericarditis or hypertrophic myocardiopathy
• left bundle branch block or cardiac pacemaker
Conditions not specifically mentioned above at the discretion of the
clinical site
Criteria for excluding patients for entry into the IDES-2
IDES Italian Diabetes and Exercise Study, BP blood pressure, eGFR estimated
glomerular filtration rate, HR heart rate, NYHA New York Heart Association
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Table 2 Study schedule
Study period
Recruitment and allocation Follow-up
Recruitment Allocation Post-allocation Close-out
Visit R1 R2 R3 R4 yr 1 F1 F2 F3 yr 2 F4 F5 F6 yr 3 F7 F8 F9
















Physician recommends increasing daily PA X X X
INT group
Theoretical session X X X
Theoretical and practical sessions X X X
Both: Standard care
Prescription X
Adjustment Xa Xa Xa Xa Xa Xa Xa Xa Xa
Assessments
Physical fitness
Run-in familiarization session X X
Assessment X X X X
Accelerometer (key)
Delivery of the key
(and daily diary)
X X X X X X X X X X
Return of the key
(and daily diary)
X X Xa Xa Xa Xa Xa Xa Xa Xa
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Table 2 Study schedule (Continued)
CV risk factors
Anthropometric data X X X X X X X X X X
Bioimpedence X X X X X X X X X X
Blood pressure X X X X X X X X X X
Blood and urine testing X X X X X X X X X X
Questionnaires
MS X X X X X X X
WHO-5 X X X X X X X
SF-36 X X X X X X X
Overview of the study visits and assessments in the IDES_2
aThree to 10 days after the visit
IDES Italian Diabetes and Exercise Study, LTPA leisure time physical activity, CV cardiovascular, MS musculoskeletal, WHO World Health Organization, SF Short Form, CON control, INT intervention
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The intervention in the INT group consists of aggre-
gated behavioral-change techniques (one individual the-
oretical exercise counseling session plus eight individual
theoretical and practical exercise-counseling sessions)
once-a-year for 3 years.
This approach has been designed based on the social
cognitive theory and health belief model and uses several
behavioral-change techniques [36] (Table 3).
Theoretical counseling sessions
The theoretical, individual, face-to-face counseling
session has been previously validated [27] and tested
successfully in clinical settings [27, 37]. In this session,
which is held in each Diabetes Clinic by a trained diabe-
tologist and lasts 30 min, the physician follows the
checklist presented in Table 4 [27].
Theoretical and practical counseling sessions
The practical counseling intervention program consists
of eight distinct but interrelated modules that cover
topics such as diabetes, free living PA and exercise and
the psychology of behavior change. The exercise sessions
(75 min each), held in three specialized gym facilities
(see Additional file 1: Appendix A) and supervised by a
certified exercise specialist, are geared to expand and
put into practice the knowledge acquired during the the-
oretical counseling session. Each exercise session is com-
posed of 30 min of aerobic exercise followed by 30 min
of resistance exercise, plus additional 15 minutes for
warm-up and cool-down (including stretching).
In these sessions, the exercise specialist improves the
patient’s knowledge of the effects of exercise on patient’s
own health, including both advantages and disadvan-
tages; conditions under which exercise should not be
done; difference between habitual and occasional exer-
cise; essential parameters of wellness such as blood pres-
sure (BP), heart rate (HR), and blood glucose. In
addition, health instructions are given to identify the dif-
ference between aerobic and resistance exercise; evaluate
the intensity of exercise; perform warm-up and stretch-
ing safely; monitor blood glucose correctly; and correct
imbalances during and after the exercise session. A
detailed list of the actions performed by the exercise spe-
cialist during the theoretical and practical counseling
sessions is presented in Table 5.
Standard care
Participants from the CON group receive general physician
recommendations for increasing the amount of daily PA
and decreasing the SED-time.
All patients receive a treatment regimen aimed at
achieving optimal glycemic, lipid, BP, and body weight
targets, as established by current guidelines [28]. This
program eventually includes glucose-, lipid- and BP-
lowering agents as needed and, when indicated, anti-
platelet drugs, plus a dietary prescription, which is pre-
ceded by a preliminary nutritional evaluation with
assessment of BMI and the individual patient require-
ments and preferences. The diet contains 55 % calories
from complex carbohydrates, 30 % from fat, and 15 %
from protein. Since all patients are overweight or obese,
they receive a low-calorie diet (negative balance of
500 kcal/day, but not less than 1500 kcal in males and
not less than 1200 kcal in females), calculated by adding
the estimated energy expenditure from routine and vol-
untary PA to the basal metabolism estimated using the
gas exchange analyzer FitMate (Cosmed, Rome, Italy).
PA is calculated by multiplying the MET scores (one
MET expresses an oxygen consumption, taken by
convention to be 3.5 ml) of the various activities by the
weekly hours spent in each of them, as reported in
the Minnesota LTPA questionnaire, and expressed as
METs ∙ h−1 ∙ week−1.
Outcome measures
The primary objective of IDES-2 is to evaluate the incre-
mental impact of intervention on the promotion and
maintenance of a physically active lifestyle as well as on
the reduction in SED-time.
Secondary objectives include testing the efficacy of the
intervention on physical fitness, modifiable cardiovascu-
lar risk factors, musculoskeletal disturbances, well-
being/depression, and health related QoL.
As physicians and exercise specialists are aware of
group assignment, outcome assessment is also un-




At screening, the volume of PA is assessed retrospect-
ively using the Minnesota LTPA questionnaire [38]. At
baseline, follow-up, and end-of-study, each participant is
outfitted with a uniaxial piezoelectric accelerometer
MyWellness Key (Technogym, Gambettola, IT) [31].
The advantages of using the MWK accelerometer relies
on the fact that it offers the possibilities of storing
30 days of continuous movement detection while exer-
cise intensity detection is aligned with other laboratory
validations [32, 39]. In addition, it was recently shown to
measure PA volume accurately and to acceptably dis-
criminate between low- and moderate-intensity PA in
individuals with T2DM [40]. The device is attached at
the waistband in midline of the right anterior hip and
detects the minutes spent at light, moderate and vigor-
ous intensities and the total volume of PA [32]. Data are
collected and downloaded on a dedicated web-portal.
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Table 4 Checklist of the theoretical counseling session
# Item Content
1 Motivation The benefits of PA/exercise are described as reported by the scientific literature for diabetic patients, stressing those appealing
most to the individual patient. Efforts are designed to convince the patient that regular PA is the pre-eminent cure for T2DM
as well as to understand what positive expectations the individual patients held from this change in behavior. The importance
of reducing SED-time is also stressed.
2 Self-efficacy Self-efficacy is promoted by patient collaboration in designing an individualized program of PA, based on age and physical
state and setting realistic personal goals.
3 Pleasure Based on the patient’s previous experience of PA/exercise, a choice of several interchangeable indoor and outdoor PAs is
proposed to identify those that are more appealing.
4 Support The supportive presence of a partner/family member/group of peers is preferred, and we offer eight structured indoor
PA/exercise sessions in the gym of the Metabolic Fitness Association.
5 Comprehension Feedback from the patients is elicited to check if they really understand the valuable advantages of the behavioral change.
After the exercise program is established, the patient is questioned to establish whether there is a really positive attitude
toward the behavioral change. Care is taken to recognize uncertainties and identify perceived impediments to PA.
6 Lack of
impediments
Potential obstacles to regular PA/exercise are identified. Instead of simply suggesting a solution, patients are invited to solve
the problem and their proposals are supplemented with advice on time management strategies.
7 Diary The patient are asked to record daily the type and time of PA they perform. On the subsequent visits (every 4 months), the
diary is used to record the amount of PA, to encourage patients’ self-efficacy, to increase the time or frequency of PA and to
overcome practical problems related to PA/exercise.
PA physical activity, T2DM type 2 diabetes mellitus, SED-time sedentary time
Table 3 Characteristics of behavioral intervention
Theoretical exercise counseling session Theoretical and practical exercise counseling sessions
Theory of behavior
change
Social Cognitive Theory Social Cognitive Theory
Health belief model Health belief model
Behavior change
techniques
Provide information on consequences of behavior in general
and individual [1, 2]
Provide information on consequences of behavior in general
and individual [1, 2]
Goal setting (behavior) [5] Goal setting (behavior) [5]
Goal setting (outcome) [6] Goal setting (outcome) [6]
Barrier identification/problem solving [8] Action planning [7]
Set graded tasks [9] Barrier identification/problem solving [8]
Prompt review of behavioral goals [10] Prompt review of behavioral goals [10]
Prompting generalization of a target behavior [15] Prompt review of outcome goals [11]
Prompt self-monitoring of behavior[16] Prompting generalization of a target behavior [15]
Provide information on where and when to perform the
behavior [20]
Prompt self-monitoring of behavior [16]
Motivational interviewing [37] Prompt self-monitoring of behavioral outcome [17]
Provide information on where and when to perform the
behavior [20]
Provide instruction on how to perform the behavior [21]




Individual face-to-face session Individual face-to-face sessions
Physician interventionist Exercise specialist interventionist
One 30-min session once a year for 3 years Eight 75-min sessions once a year for 3 years
Theories of behavior change, behavior change techniques, and mode of delivery of intervention in the IDES_2
Numbers in the square brackets correspond with the code assigned to each behavior change technique described in ref #36
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Each participant wears the device for 4 months at base-
line and for 7 consecutive days every 4 months there-
after. Upon waking, participants attach the device
(immediately after bathing or showering) and wear it all
day (except if swimming) up to bedtime, for at least
10 h/day. Patients are also asked to report on a daily
diary the hours spent wearing the instrument, sleeping
and napping, and performing nonaccelerometer record-
able PAs such as swimming, cycling, skiing, etc.
The time the patient is awake and is not wearing the ac-
celerometer, is assumed to be spent in sedentary activities
(for example, taking a shower or getting dressed), unless
spent in PAs that cannot be performed while wearing the
accelerometer (for example, swimming). SED-time is then
calculated by adding this time to that recorded by the
accelerometer with readings <100 counts/min, a threshold
that corresponds with sitting, reclining, or lying down,
that is, to <1.5 METS [41].
Matthews’ cut-points are used to identify the time
spent in light intensity (100 to 1951 counts/min corre-
sponding to 1.5 to 2.9 METs) [42], whereas Freedson’s
cut-points are used to determine the time spent in PA of
moderate intensity (1952 to 5724 counts/min corre-
sponding to 3 to 5.9 METs) and vigorous intensity
(≥5725 counts/min corresponding to ≥6 METs) [43].
The time spent in non-accelerometer-recordable PAs, as
reported on the daily diary, is added to that recorded by
the accelerometer, according to the intensity of each
Table 5 List of the actions performed by the exercise specialist during the theoretical and practical counseling sessions
# Action
1 Establishes clinical condition and physical fitness and identifies the adequate exercise protocol (using a homemade exercise algorithm) on the
basis of previous evaluations.
2 Measures BP, HR, and glucose level before and after each exercise session and provides feedback to the subject on the effect of the specific
exercise adopted.
3 Instructs the patient to perform these measurements, indicates the range of glycemic values allowing or contraindicating exercise, and suggests
to start with resistance exercise when glycemia is on the low side of the range, especially for those treated with insulin or secretagogues.
4 Reviews with the patient the structure of the exercise session (warm-up, exercise, and cool-down phases), instructs on how to perform a safe
warm-up and cool down, providing practical examples for the different exercise types, and stressing the importance of the gradualism of the
increase and decrease of the intensity for the warm up and cool down, respectively.
5 Explains the difference between aerobic and resistance exercise, proving practical examples of the different exercise forms (endurance exercise
machines, resistance exercise devices, free body exercises).
6 For aerobic exercise training, illustrates the correct exercise progression and control and, throughout the counseling sessions, encourages the
patients to progressively increase the exercise intensity, instructing on how to identify and control light, moderate and vigorous intensity on the
basis of breathing frequency (talk test), rate of perceived exercise, and HR. As an example, exercise intensity is explained on the basis of the
ability to perform a conversation as follows: o light intensity: “allows to respond to conversation without problems.” o moderate intensity: “allows
to carry on a conversation but with some difficulties.” o vigorous intensity: “ the speech is limited to short phrases.”
7 Especially for unsupervised PA/exercise and for patients with complications, advises the patients to work at low-to-moderate intensity, as it is the
one allowing to reduce the risk of adverse events while providing substantial benefits.
8 With regard to the volume of aerobic exercise, gives examples on how to comply with the exercise recommendations on the minimum amount
of PA/exercise providing health benefits, and stressing that adding more PA/exercise will results in additional benefits.
9 Describes the correct way of increasing training volume, augmenting first duration and then intensity, especially in patients with complications.
10 Explains the difference between weight bearing and non-weight-bearing exercise and the relevance for the subjects with complications, provid-
ing practical examples.
11 For resistance exercise training, provides examples on the exercise taxing the major muscle groups (eight to 10 exercises), explaining (and
checking the learning of) the correct exercise technique, and illustrates a typical sequence of resistance exercises, alternating opposing muscle
groups and/or upper and lower body exercises.
12 Explains the concept that a higher repetitions number corresponds to a light weight to be lifted (therefore lighter intensity) and vice versa, and
teaches the correct breathing pattern during the different resistance exercises adopted, reminding that breath holding (Valsalva maneuver)
should be avoided.
13 Instructs to perform multiples sets (for example, two to three sets) with adequate recovery between them (for example, 2 min), depending on
the intensity adopted (less repetitions per set usually equal longer recovery time).
14 Identifies indicated and contraindicated resistance exercises on the basis of the specific patient’s complications.
15 Provides examples on how to substitute the typical exercises executed in the gym setting with other forms of PA/exercise to be performed
outside the gym, reminding patients that new forms of unsupervised PA/exercise should be adopted after consulting the exercise specialist.
16 Helps the patient to organize a typical working day and weekend in order to find time and space for performing any type of PA (home,
commuting, occupational, and LT), reduce the SED-time, and remove potential obstacles.
17 Assists the patient in setting behavior and outcome goals as well as in the choice of the indoor and outdoor PAs that are the most appealing
and feasible.
BP blood pressure, HR heart rate, PA physical activity
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activity [44]. Moderate-intensity PA is combined with
vigorous-intensity PA into the MVPAs, as participants
spend little time in vigorous-intensity PA.
Assessment of physical fitness
Parameters of physical fitness, that is, cardiorespiratory
fitness, strength and flexibility, are evaluated at baseline,
12 months, 24 months, and end-of-study. The tests are
preceded by two consecutive run-in sessions to allow
the patients to become familiar with the testing devices
and protocols.
Cardiorespiratory fitness is assessed by a maximal
treadmill exercise test using a Balke protocol [45]. The
treadmill speed is set at 88 m/min and the grade is 0 % dur-
ing the first minute, 2 % during the second minute, and is
then increased every minute by 1 %; after 25 minutes, the
treadmill grade is kept constant, whereas the speed is in-
creased by 5.4 m/min every minute. Patients are instructed
not to hold the treadmill rails and are verbally encouraged
to reach volitional exhaustion, as reported by the patient or
by the physician for medical reasons. The time to exhaus-
tion is used to estimate the maximal oxygen uptake, given
the high correlation between these two parameters [46].
For strength assessment, isometric muscle strength
is measured by means of a strain gauge tensiometer
(Digimax, Mechatronic GmbH, Germany), as previ-
ously described [47]. Isometric tests have been chosen
since they are reproducible [48, 49], do not require
complex execution technique, and can therefore be
easily performed by both trained and untrained sub-
jects. Lower limb muscle strength is assessed by max-
imal voluntary contractions (MVCs) performed at a
costumed leg extension machine (Technogym). The
angle at the knee and the hip is fixed at 90°. Upper
body muscle strength is assessed by MVCs performed
at a shoulder press (Technogym) along the sagittal
plane, with a 90° and 45° angle at the elbow and be-
tween the upper arm and the trunk, respectively. These
exercise modalities have been chosen in order to test
muscle chains involved in the fundamental activities of
daily living. In both tests, subjects are asked to exert
their maximal force with both limbs simultaneously
and to maintain it for at least 2–3 s before relaxing.
For each exercise, three MVC are performed, with a 3-
min rest interval between contractions. Participants
are asked to perform additional contractions if the
MVC of their last attempt exceeds the previous by at
least 5 %. During the MVCs, verbal encouragement is
provided, always by the same investigator for all
subjects.
For hip and trunk flexibility assessment, a standard
bending test is executed [27]. Standing on a step with
legs fully extended, patients are asked to bend the torso
forward to try to touch the ground with their fingertips.
The test is performed three times and the distance
between the finger and the ground is measured by the
exercise specialist at the third attempt.
Assessment of modifiable cardiovascular risk factors
The following modifiable cardiovascular risk factors are be-
ing evaluated at baseline, end-of-study, and every 4 months
in-between: HbA1c; fasting plasma glucose (FPG); serum in-
sulin; C-peptide; BMI; waist circumference; body compos-
ition; BP; triglycerides; total, LDL and HDL cholesterol;
high sensitivity-C-reactive protein (hs-CRP); aspartate
aminotransferase (AST); alanine aminotransferase (ALT);
γ-glutamyl-transpeptidase (γ-GT); creatine kinase (CK);
complete blood count; uric acid; blood urea nitrogen
(BUN); serum creatinine; urinalysis; and albumin/creatinine
ratio on first-voided urine samples.
Body weight and height are measured using a scale
and stadiometer, and BMI is then calculated as weight
(kg)/height (m2), whereas waist circumference is taken
at the umbilicus. Body composition is evaluated by
assessing the fat mass and fat-free mass by the use of a
body fat monitor (Tanita BF664, Vernon Hills, IL,
USA). BP is recorded with a sphygmomanometer after
a 5-minute rest while the patient remains seated with
the arm at the heart level.
Biochemical tests are centralized at the Laboratory
of Clinical Chemistry of Sant’Andrea Hospital, an
accredited and ISO9001 certified structure, using
standard analytical techniques (Table 6). The Homeo-
stasis Model Assessment-Insulin Resistance (HOMA-
IR) index is calculated from the FPG and insulin
levels [50]. The glomerular filtration rate (GFR) is es-
timated from the serum creatinine by the use of the
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation [51]. Global and fatal CHD 10-
year risk scores are calculated using the United
Kingdom Prospective Diabetes Study (UKPDS) risk
engine [52].
Assessment of musculoskeletal disturbances
Musculoskeletal symptoms are evaluated by the use of a
50-item self-report questionnaire (see Additional file 1:
Appendix C2) [33], which investigates shoulder, arm,
elbow, wrist, hand, spine, hip, knee, ankle, and foot
problems.
Assessment of well-being/depression
Screening for depression is performed by asking partici-
pants to fill in the WHO-5 Well-being Index, a five-item
questionnaire (see Additional file 1: Appendix C3) [34],
which was found to be suitable for use in outpatients
with type 1 and T2DM [53].
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Assessment of health-related QoL
Health-related QoL is evaluated using the Italian
version [54] of the SF-36 health survey (ISF-36) (see
Additional file 1: Appendix C4) [35], which yields
four physical and four mental health component
scores and has been previously validated in subjects
with T2DM [55, 56]. The physical and mental com-
ponent summary measures (PCS and MCS, respect-
ively) are normalized to a population mean of 50
and SD of 10.
Adverse events
Adverse events are reported at intermediate visits and,
for INT subjects, also at supervised sessions, by complet-
ing a standard form.
Dissemination policy
Trial results will be communicated to participants via
the website of the Metabolic Fitness Association
(http://www.metabolicfitness.it/) and by organizing a
dedicated event. Results will by also communicated to
the scientific via publication and to the public via
press release. The final report will follow the main
CONSORT 2010 guideline and will be extended as
necessary for a non-pharmacological intervention.
After publication of the results, public access to the
full protocol, participant-level dataset, and statistical
code will be eventually granted upon request.
Data collection, storage and security
Data collected via web into the IDES_2 database and
downloaded from the accelerometers are saved to a
password-protected server in the Metabolic Fitness
Association. These data are accessed only by members
of the research team. Once all data have been uploaded
to the server, they will be securely deleted from the
recording devices. Patient questionnaire data will be
anonymized and stored in locked filing cabinets in the
Metabolic Fitness Association.
Statistical analysis
Sample size calculation is based on preliminary ac-
celerometer data showing that daily PA in sedentary,
physically inactive T2DM patients is 24.2 ± 9.4 METs
∙ h−1 ∙ wk−1. To observe a 15 % increase in daily PA
with a statistical power of 90 % (α = 0.05) by un-
paired t-test, 142 patients per arm are needed (284
total). A sample size of 300 patients will allow sup-
porting a 5 % dropout rate, as detected in the EXE
group from the IDES [14].
Table 6 Laboratory tests
Analyte Method Manufacturer
HbA1c HPLC (Adams TMA1C HA-8160) Menarini Diagnostics, Florence, Italy
FPG VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Insulin Chemiluminiscent immunometric assays (Immulite 2000 Thes) Diagnostic Products Corporation, Los Angeles, CA, USA
C-peptide Chemiluminiscent immunometric assays (Immulite 2000 Thes) Diagnostic Products Corporation, Los Angeles, CA, USA
Triglycerides VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Total cholesterol VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
LDL cholesterol VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
HDL cholesterol VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
hs-CRP VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
AST VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
ALT VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
γ-GT VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
CK VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Complete blood count VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Uric acid VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
BUN VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Serum creatinine VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Urinary albumin mAlb VITROS Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Urinary creatinine VITROS 5,1 FS Chemistry System Ortho Clinical Diagnostics Inc, Raritan, NJ, USA
Biochemical measurements in the IDES-2
IDES Italian Diabetes and Exercise Study, HbA1c hemoglobin A1c, HPLC high-performance liquid chromatography, FPG fasting plasma glucose, hs-CRP high
sensitivity-C-reactive protein, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GT γ-glutamyl-transpeptidase, CK creatine kinase, BUN blood
urea nitrogen
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The χ2 test for categorical variables and the Student’s t
test or the corresponding nonparametric Mann–Whitney
test for continuous variables will be utilized to compare
patients’ characteristics at baseline.
The intent-to-treat analysis for primary and secondary
endpoints will be applied to all randomized patients with
a baseline and at least one post-baseline value. The effi-
cacy of the intervention, as compared with standard
care, on the primary and secondary endpoints will be
assessed by a repeated measures analysis of covariance
(ANCOVA - using PROC MIXED in SAS software) of
change from baseline to the end-of-study. In case of dif-
ferences between groups in baseline values, we will
consider a baseline adjustment to improve power. The
differences between end-of-study and baseline QoL
scores and summary measures between the two groups
will be compared using the Mann–Whitney U-test,
while changes in QoL parameters within each group
(end-of-study versus baseline) will be tested using the
Wilcoxon test.
To account for change in medication throughout the
study period, which might affect performance with re-
spect to cardiovascular risk factors, we will perform both
multiple regression and sensitivity analyses. In the
regression models, the dependent variable will be repre-
sented by baseline to end-of-study changes. Treatment
at baseline and treatment initiation during the study will
be included in the model as dichotomous variables (yes
versus no), whereas drug dosage will be not taken into
consideration. Sensitivity analysis will be conducted by
comparing study arms after exclusion of the patients
who modified the treatment.
In order to treat attrition, we will assume that data are
missing at random, use adjustment methods for missing
data, and conduct a sensitivity analysis to assess the ro-
bustness of inferences about treatment effects to various
missing-data assumptions [57]. In particular, repeated
measures models with an autoregressive correlation type
matrix will be applied in order to account for both miss-
ingness at random and potential correlation within sub-
jects. These methods are more efficient in that they
allow evaluating all subjects, even those with incomplete
data [58, 59]. Moreover, to guarantee replicability and
avoid outcome selective reporting, a fully specified stat-
istical analysis plan will be written before unmasking.
Statistical analyses will be performed by at the CORE
using SAS software release 9.3 (Cary, NC, USA).
Discussion
Meta-analyses of small-sized studies showed that
structured aerobic exercise is effective in improving
cardio-respiratory fitness [60] as well as glycemic con-
trol and other modifiable cardiovascular risk factors
[61, 62] in subjects with T2DM. These data suggested
that additional benefits, beyond those of the PA itself,
may be provided by exercise (that is, by planned or
structured PA that involves repetitive bodily move-
ments performed to improve or maintain one or more
of the components of physical fitness, such as cardiore-
spiratory and muscular fitness) [8]. Based on these
early studies [60–62], as well as on subsequent RCTs
[11, 12, 14–16] and a large meta-analysis [13], PA/ex-
ercise has become an integral part of T2DM manage-
ment [7–10].
However, implementation of PA/exercise in routine
clinical practice for adults with T2DM is hindered by
several impediments [21]. Compliance to PA/exercise
recommendations is usually poor in sedentary and phys-
ically inactive patients such as those suffering from
metabolic disorders, since sustained changes in lifestyle
may require much time and effort. In fact, both RCTs
and observational studies showed that health benefits
from PA/exercise are volume-dependent, since they start
beyond a certain threshold, increase almost linearly
thereafter, and finally plateau as large volumes are
achieved [14, 26, 63]. However, in the long-term, benefi-
cial effects might be obtained also with smaller volumes
of daily PA. Previous studies showed that an increase of
1 MET was associated with approximately an 18 % re-
duced risk of death [64, 65] and an increase of 1,000
steps resulted in a reduction of postprandial blood glu-
cose by 1.6 mmol/L over a period of 2 years [66]. In
addition, in the European Prospective Investigation into
Cancer and Nutrition Study (EPIC), the greatest reduc-
tions in mortality risk were observed between the two
lowest activity groups across levels of total and abdominal
adiposity, suggesting that efforts to encourage even small
increases in activity in sedentary/inactive individuals may
be beneficial to public health [67]. Finally, increasing over-
all PA may have beneficial effects on disease progression
and cardiovascular risk in patients with T2DM also by
decreasing the amount of SED-time [19, 20].
Thus, behavioral strategies favoring of an increase of
PA/exercise as well as a reduction in SED-time may be
successful in these individuals, as shown in trials for
T2DM prevention [22, 23] and treatment [24]. To this
end, counseling interventions focused exclusively on PA
were found to be more effective in promoting PA than
those targeting multiple behaviors [68] and diabetes self-
management education programs were shown to provide
clinically meaningful improvements in glycemic control
when combined with ≥11 contact hours with delivery
personnel [69]. Unfortunately, acceptable, feasible, and
validated behavioral interventions are lacking. Available
studies are heterogeneous in that they differ on the
theory of behavior change used to underpin them (for
example, the transtheoretical model, social cognitive
theory, or precede/proceed model); the behavior change
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techniques used to promote change (for example, goal
setting, use of follow-up prompts, or provision of feed-
back on performance); and the modalities of interven-
tion delivery (for example, frequency and duration of
contact and one-to-one versus group delivery) [25]. In
other circumstances, behavioral interventions have omit-
ted details on these items and also on how intervention
was operationalized and evaluated, thus limiting its effi-
cacy and replication outside the research setting [25]. Fi-
nally, available studies generally involved small samples
for short periods, and in most of them, changes in PA
were not objectively measured. PA and SED-time vari-
ables in these studies have typically been derived from
self-report measures, generally a 1-week recall. In
addition to the imprecision associated with such mea-
sures, it is also difficult to accurately capture the total
sedentary behavior or light intensity PA by questionnaire
[70]. Light-intensity PA, which includes activities such as
washing dishes, ironing, and other routine domestic or
occupational tasks, is the predominant determinant of
variability in total daily energy expenditure [71].
Barriers that are outside the patient’s own control in-
clude lack of specific knowledge on the part of both phy-
sicians and exercise trainers and lack of dedicated
facilities. In particular, these is a lack of evidence-based
training programs to equip healthcare professionals with
a range of intervention-specific competencies (know-
ledge and skills) and confidence to support adults with
T2DM to become more physically active in the long-
term. A systematic review and meta-analysis of 17 RCTs
reported use of treatment fidelity measures in a majority
of studies in terms of study design (for example, consist-
ent duration and frequency of sessions across trial arms)
and monitoring to improve receipt of intervention com-
ponents and enactment of intervention–related know-
ledge and skills by patients. In contrast, treatment
fidelity strategies to monitor and improve provider train-
ing and delivery of treatment in practice were frequently
omitted (for example, use of standardized training mate-
rials, observation of intervention implementation during
training with intervention providers and recipients) [72].
Training of intervention providers and treatment fidelity
assessment are important for ensuring reproducibility of
intervention-related skills in clinical practice and in-
creasing the likelihood of implementation in routine
clinical care [73, 74].
The IDES_2 is an RCT testing the incremental impact
of a behavioral intervention strategy for the promotion
and long-term maintenance of free-living PA/exercise as
well as for the reduction in SED-time in subjects with
T2DM. This strategy is based on solid theoretical
grounds and uses several behavior change techniques,
two factors which were found to improve effectiveness
of behavioral intervention [72]. In addition, physicians
and exercise specialists have been trained to administer
a structured exercise counselling and prescribe PA/exer-
cise to subjects suffering from metabolic disorders and
to supervise exercise sessions, including monitoring of
clinical parameters, for these individuals, respectively.
Moreover, the large sample size, the long study duration,
and the objective measurement of PA using an acceler-
ometer which allows monitoring for long periods of time
will provide statistically significant and scientifically ro-
bust data on the efficacy of this intervention. Finally, im-
plementation of this program in routine clinical practice
is certainly more feasible than that of life-long super-
vised training programs, the application of which is
hampered by the high costs for both health services and
patients.
Based on these considerations, we expect that such be-
havioral intervention would offer a feasible procedure
for the promotion and long-term maintenance of free-
living PA/exercise as well as the reduction in SED-time
and thus meet the call for a change of paradigm to move
beyond the limited clinical focus by including theoretic-
ally population-based and "real-life" approaches for the
management of T2DM.
With regard to possible risks of bias, we anticipate
that, according to the Cochrane Collaboration [75], the
risk of selection bias is low, due to the use of adequate
methods for sequence generation and allocation se-
quence concealment, although patients who agree to
participate in a lifestyle intervention program might be
different from those who refuse. Moreover, though
blinding of participants and investigators is impossible
in exercise intervention studies, the risks of perform-
ance, detection, and attrition bias are also limited for
several reasons. Regarding performance, despite the fact
that independently of intervention, participants might be
influenced by knowledge of group assignment in adopt-
ing and maintaining a physically active lifestyle, the pos-
sibility that unblinding to group assignment may result
in an overestimation or an underestimation of interven-
tion effects is low. On the one hand, subjects from the
control group of the IDES performed a considerable
amount of PA [14] and, though PA measurements are
known to affect physical activity behavior [76], this
would impact on PA volume of both groups. On the
other hand, investigators are asked not to provide sub-
jects from the control group with PA advice other than
general recommendations for increasing the amount of
daily PA (and decreasing the SED-time), and intensifica-
tion of pharmacological treatment to compensate for
lower PA in these individuals will be accounted for in
the statistical analysis. Regarding detection, because the
primary outcome and some secondary outcomes (phys-
ical fitness and cardiovascular risk factors) are objective,
the risk of bias is low on both the participant’s and
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investigator’s side, although study subjects might be in-
fluenced by knowledge of group assignment when filling
in questionnaires for musculoskeletal disturbances, well-
being/depression, and health-related QoL. Regarding
attrition, in the IDES, knowledge of group assignment
did not affect remaining in the trial for the entire study
period as participants from the control group dropped
out at a rate and for reasons similar to those of the exer-
cise group [14]. Moreover, as reported above, the risk of
attrition bias due to missing data has been adequately
prevented and will be treated according to a recent
National Research Council report on the topic [57].
In conclusion, this trial tests the hypothesis that a theor-
etical and practical behavioral intervention strategy is more
effective than standard care for the promotion and long-
term maintenance of free-living PA/exercise as well as for
the reduction in SED-time, while reducing modifiable
cardiovascular risk factors and improving MS symptoms,
well-being, and health-related QoL in T2DM patients.
Trial status
Recruitment was ongoing at the time of manuscript
submission.
Additional file
Additional file 1: See Appendix A for the complete list of the
IDES_2 Investigators; Appendix B for the SPIRIT 2013 Checklist;
Appendix C for Forms and Questionnaires; and Appendix D for World
Health Organization Trial Registration Data Set. (DOC 252 kb)
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